Holen Sie sich die Stockscreener-App
2.07
0.48%
-0.01
Schlusskurs vom Vortag:
$2.08
Offen:
$2.08
24-Stunden-Volumen:
70,388
Relative Volume:
0.25
Marktkapitalisierung:
$35.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.48%
1M Leistung:
+0.00%
6M Leistung:
+108.00%
1J Leistung:
-39.47%
1-Tages-Spanne:
$2.07
$2.085
1-Wochen-Bereich:
$2.07
$2.09
52-Wochen-Spanne:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
Mural Oncology Plc
Sektor
Branche
Telefon
353 1 905 8020
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie MURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.07 | 36.04M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-04 | Eingeleitet | Morgan Stanley | Overweight |
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
Does Mural Oncology plc qualify in momentum factor screeningPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Citadel Group discloses 1.35% position in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.35% position in Mural Oncology - Investing.com India
Combining machine learning predictions for Mural Oncology plcEarnings Recap Summary & Fast Entry High Yield Tips - newser.com
What recovery options are there for Mural Oncology plcJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
Citadel Group discloses 1.34% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.34% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.33% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.33% stake in Mural Oncology - Investing.com
Detecting support and resistance levels for Mural Oncology plc2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
What MACD signals say about Mural Oncology plcJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
Visual trend scoring systems applied to Mural Oncology plc2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Will Mural Oncology plc outperform the marketMarket Activity Recap & Precise Buy Zone Tips - newser.com
News impact scoring models applied to Mural Oncology plcQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Will Mural Oncology plc continue its uptrendWeekly Investment Summary & AI Optimized Trade Strategies - newser.com
Quantitative breakdown of Mural Oncology plc recent moveQuarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Is Mural Oncology plc stock undervalued vs historical averagesTrade Ideas & Risk Managed Investment Entry Signals - newser.com
Cancer stocks rebound, outpacing broader markets in Q3 2025 - BioWorld MedTech
Citadel Group discloses 1.32% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 1.32% stake in Mural Oncology - Investing.com India
Trium Capital discloses 11% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Trium Capital discloses 11% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.56% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.56% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.54% stake in Mural Oncology By Investing.com - Investing.com Nigeria
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders - Benzinga
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Mural Oncology Plc-Aktie (MURA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):